Werner Poewe
Impact in
- Neurology top 0.01%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Neurological diseases and metabolism
- Cellular and Molecular Neuroscience top 0.02%
- Genetic Neurodegenerative Diseases
Papers in
- Neurology 521
- Parkinson's Disease Mechanisms and Treatments 457
- Neurological disorders and treatments 262
- Botulinum Toxin and Related Neurological Disorders 96
- Neurological diseases and metabolism 43
-
- Genetic Neurodegenerative Diseases 89
- Co-authors
- Gregor K. Wenning (203 shared papers)Klaus Seppi (205 shared papers)Olivier Rascol (88 shared papers)Anthony E. Lang (22 shared papers)Eduardo Tolosa (43 shared papers)Christopher G. Goetz (25 shared papers)Glenda M. Halliday (8 shared papers)Cristina Sampaio (28 shared papers)
- Journals
- Movement Disorders (163 papers)Neurology (53 papers)Parkinsonism & Related Disorders (37 papers)Journal of Neurology (27 papers)The Lancet Neurology (22 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Werner Poewe
681 papers receiving 57.8k citations
Werner Poewe's Hit Papers
Peers
Comparison fields: 5 of 197
- Neurology 37.9k
- Neurology 5.6k
- Cellular and Molecular Neuroscience 11.4k
- Physical Therapy, Sports Therapy and Rehabilitation 1.7k
- Cognitive Neuroscience 6.4k
Countries citing papers authored by Werner Poewe
This map shows the geographic impact of Werner Poewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Poewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Poewe more than expected).
Fields of papers citing papers by Werner Poewe
This network shows the impact of papers produced by Werner Poewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Poewe. The network helps show where Werner Poewe may publish in the future.
Co-authors
The 25 scholars most cited alongside Werner Poewe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 690 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MDS clinical diagnostic criteria for Parkinson's disease Hit paper breakdown → | 2015 | 5072 |
| 2 | Parkinson disease Hit paper breakdown → | 2017 | 3477 |
| 3 | Second consensus statement on the diagnosis of multiple system atrophy Hit paper breakdown → | 2008 | 2292 |
| 4 | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease Hit paper breakdown → | 2004 | 1799 |
| 5 | Challenges in the diagnosis of Parkinson's disease Hit paper breakdown → | 2021 | 1111 |
| 6 | MDS research criteria for prodromal Parkinson's disease Hit paper breakdown → | 2015 | 898 |
| 7 | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease Hit paper breakdown → | 2011 | 867 |
| 8 | Rivastigmine for Dementia Associated with Parkinson's Disease Hit paper breakdown → | 2004 | 797 |
| 9 | The diagnosis of Parkinson's disease Hit paper breakdown → | 2005 | 635 |
| 10 | Early consolidation in human primary motor cortex Hit paper breakdown → | 2002 | 622 |
| 11 | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study Hit paper breakdown → | 2003 | 607 |
| 12 | A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease Hit paper breakdown → | 2009 | 591 |
| 13 | Non‐motor symptoms in Parkinson’s disease Hit paper breakdown → | 2008 | 573 |
| 14 | Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia Hit paper breakdown → | 2012 | 561 |
| 15 | Depression rating scales in Parkinson's disease: Critique and recommendations Hit paper breakdown → | 2007 | 528 |
| 16 | 2005 | 462 | |
| 17 | 2004 | 439 | |
| 18 | 2005 | 429 | |
| 19 | 2004 | 428 | |
| 20 | 2001 | 399 |
About Werner Poewe
Werner Poewe is a scholar working on Neurology, Cellular and Molecular Neuroscience, Epidemiology, Neurology and Cognitive Neuroscience, having authored 690 papers that have together received 59.3k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (457 papers), Neurological disorders and treatments (262 papers), Botulinum Toxin and Related Neurological Disorders (96 papers), Genetic Neurodegenerative Diseases (89 papers), Restless Legs Syndrome Research (66 papers), Neurological diseases and metabolism (43 papers), Autism Spectrum Disorder Research (24 papers) and Sleep and Wakefulness Research (21 papers). The work is most often cited by research in Neurology (37.9k citations), Neurology (5.6k citations), Cellular and Molecular Neuroscience (11.4k citations), Physical Therapy, Sports Therapy and Rehabilitation (1.7k citations) and Cognitive Neuroscience (6.4k citations). Werner Poewe has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Gregor K. Wenning, Klaus Seppi, Olivier Rascol, Anthony E. Lang, Eduardo Tolosa, Christopher G. Goetz, Glenda M. Halliday, Cristina Sampaio, Anette Schrag and Birgit Högl. Their work appears in journals such as Movement Disorders, Neurology, Parkinsonism & Related Disorders, Journal of Neurology and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.